Skip to main content
. 2023 May 24;14:1189323. doi: 10.3389/fimmu.2023.1189323

Table 3.

Nanotherapies targeting non-cellular components in HNSCC.

Nanoparticles Cargoes Target Response Application Refs
CECMa Cisplatin and metformin Hypoxia Targeting the hypoxic tumor region, and co-delivers cisplatin and metformin Co-delivers cisplatin and metformin (70)
TiO2 Ru complex and HIF-1α siRNA Hypoxia Silencc of HIF-1α Combined with PDT (71)
Nanohydrogel nano DOX and nano ICG ECM Sustained release nano DOX and nano ICG with the presence of MMPs Combined with 808nm NIR irradiation (72)
Extracellular vesicle MMP13 ECM Inducing EMT of the recipient normoxic cell Knocking down MMP13 in EVs (73)